Sterile Vials Market Research Report
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Sterile Vials Market
4. Market Overview
4.1. Introduction
4.1.1. Market Introduction
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Trends
4.4. Global Sterile Vials Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
5. Key Insights
5.1. Recent Development (industry updates, merger & acquisitions)
5.2. Key Vendor and Distributor Analysis
5.3. Sterile Vials Pricing Analysis
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Sterile Vials Market Analysis and Forecasts, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value and Volume Forecast by Product, 2017–2031
6.3.1. Sterile Empty Vial
6.3.1.1. Sterile Evacuated Vial
6.3.1.2. Sterile Nitrogen Filled Vial
6.3.1.3. Sterile Air Filled Vial
6.3.2. Sterile Liquid Filled Vial
6.3.2.1. Sterile Saline Filled Vial
6.3.2.2. Sterile Media Filled Vial
6.3.2.3. Sterile Water Filled Vial
6.3.3. Individual Sterilized Components (ISCs)
6.4. Market Attractiveness Analysis, by Product
7. Global Sterile Vials Market Analysis and Forecast, by Volume
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value and Volume Forecast, by Volume, 2017–2031
7.3.1. <2ml
7.3.2. 2 ml to 5ml
7.3.3. 5 ml to 10 ml
7.3.4. 10 ml to 20 ml
7.3.5. >20ml
7.4. Market Attractiveness Analysis, by Volume
8. Global Sterile Vials Market Analysis and Forecast, by Material
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value & Volume Forecast, by Material, 2017–2031
8.3.1. Glass
8.3.2. Plastic
8.4. Market Attractiveness Analysis, by Material
9. Global Sterile Vials Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value and Volume Forecast, by End-user, 2017–2031
9.3.1. Clinical Labs
9.3.2. Compounding Labs
9.3.3. Biopharmaceutical Companies
9.3.4. CMOs
9.3.5. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Sterile Vials Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value and Volume Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Country/Region
11. North America Sterile Vials Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value and Volume Forecast, by Product, 2017–2031
11.2.1. Sterile Empty Vial
11.2.1.1. Sterile Evacuated Vial
11.2.1.2. Sterile Nitrogen Filled Vial
11.2.1.3. Sterile Air Filled Vial
11.2.2. Sterile Liquid Filled Vial
11.2.2.1. Sterile Saline Filled Vial
11.2.2.2. Sterile Media Filled Vial
11.2.2.3. Sterile Water Filled Vial
11.2.3. Individual Sterilized Components (ISCs)
11.3. Market Value and Volume Forecast, by Volume, 2017–2031
11.3.1. <2ml
11.3.2. 2 ml to 5ml
11.3.3. 5 ml to 10 ml
11.3.4. 10 ml to 20 ml
11.3.5. >20ml
11.4. Market Value & Volume Forecast, by Material, 2017–2031
11.4.1. Glass
11.4.2. Plastic
11.5. Market Value and Volume Forecast, by End-user, 2017–2031
11.5.1. Clinical Labs
11.5.2. Compounding Labs
11.5.3. Biopharmaceutical Companies
11.5.4. CMOs
11.5.5. Others
11.6. Market Value and Volume Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Volume
11.7.3. By Material
11.7.4. By End-user
11.7.5. By Country
12. Europe Sterile Vials Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value and Volume Forecast, by Product, 2017–2031
12.2.1. Sterile Empty Vial
12.2.1.1. Sterile Evacuated Vial
12.2.1.2. Sterile Nitrogen Filled Vial
12.2.1.3. Sterile Air Filled Vial
12.2.2. Sterile Liquid Filled Vial
12.2.2.1. Sterile Saline Filled Vial
12.2.2.2. Sterile Media Filled Vial
12.2.2.3. Sterile Water Filled Vial
12.2.3. Individual Sterilized Components (ISCs)
12.3. Market Value and Volume Forecast, by Volume, 2017–2031
12.3.1. <2ml
12.3.2. 2 ml to 5ml
12.3.3. 5 ml to 10 ml
12.3.4. 10 ml to 20 ml
12.3.5. >20ml
12.4. Market Value & Volume Forecast, by Material, 2017–2031
12.4.1. Glass
12.4.2. Plastic
12.5. Market Value and Volume Forecast, by End-user, 2017–2031
12.5.1. Clinical Labs
12.5.2. Compounding Labs
12.5.3. Biopharmaceutical Companies
12.5.4. CMOs
12.5.5. Others
12.6. Market Value and Volume Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Volume
12.7.3. By Material
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Sterile Vials Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value and Volume Forecast, by Product, 2017–2031
13.2.1. Sterile Empty Vial
13.2.1.1. Sterile Evacuated Vial
13.2.1.2. Sterile Nitrogen Filled Vial
13.2.1.3. Sterile Air Filled Vial
13.2.2. Sterile Liquid Filled Vial
13.2.2.1. Sterile Saline Filled Vial
13.2.2.2. Sterile Media Filled Vial
13.2.2.3. Sterile Water Filled Vial
13.2.3. Individual Sterilized Components (ISCs)
13.3. Market Value and Volume Forecast, by Volume, 2017–2031
13.3.1. <2ml
13.3.2. 2 ml to 5ml
13.3.3. 5 ml to 10 ml
13.3.4. 10 ml to 20 ml
13.3.5. >20ml
13.4. Market Value & Volume Forecast, by Material, 2017–2031
13.4.1. Glass
13.4.2. Plastic
13.5. Market Value and Volume Forecast, by End-user, 2017–2031
13.5.1. Clinical Labs
13.5.2. Compounding Labs
13.5.3. Biopharmaceutical Companies
13.5.4. CMOs
13.5.5. Others
13.6. Market Value and Volume Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Volume
13.7.3. By Material
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Sterile Vials Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value and Volume Forecast, by Product, 2017–2031
14.2.1. Sterile Empty Vial
14.2.1.1. Sterile Evacuated Vial
14.2.1.2. Sterile Nitrogen Filled Vial
14.2.1.3. Sterile Air Filled Vial
14.2.2. Sterile Liquid Filled Vial
14.2.2.1. Sterile Saline Filled Vial
14.2.2.2. Sterile Media Filled Vial
14.2.2.3. Sterile Water Filled Vial
14.2.3. Individual Sterilized Components (ISCs)
14.3. Market Value and Volume Forecast, by Volume, 2017–2031
14.3.1. <2ml
14.3.2. 2 ml to 5ml
14.3.3. 5 ml to 10 ml
14.3.4. 10 ml to 20 ml
14.3.5. >20ml
14.4. Market Value & Volume Forecast, by Material, 2017–2031
14.4.1. Glass
14.4.2. Plastic
14.5. Market Value and Volume Forecast, by End-user, 2017–2031
14.5.1. Clinical Labs
14.5.2. Compounding Labs
14.5.3. Biopharmaceutical Companies
14.5.4. CMOs
14.5.5. Others
14.6. Market Value and Volume Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Volume
14.7.3. By Material
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Sterile Vials Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value and Volume Forecast, by Product, 2017–2031
15.2.1. Sterile Empty Vial
15.2.1.1. Sterile Evacuated Vial
15.2.1.2. Sterile Nitrogen Filled Vial
15.2.1.3. Sterile Air Filled Vial
15.2.2. Sterile Liquid Filled Vial
15.2.2.1. Sterile Saline Filled Vial
15.2.2.2. Sterile Media Filled Vial
15.2.2.3. Sterile Water Filled Vial
15.2.3. Individual Sterilized Components (ISCs)
15.3. Market Value and Volume Forecast, by Volume, 2017–2031
15.3.1. <2ml
15.3.2. 2 ml to 5ml
15.3.3. 5 ml to 10 ml
15.3.4. 10 ml to 20ml
15.3.5. >20ml
15.4. Market Value & Volume Forecast, by Material, 2017–2031
15.4.1. Glass
15.4.2. Plastic
15.5. Market Value and Volume Forecast, by End-user, 2017–2031
15.5.1. Clinical Labs
15.5.2. Compounding Labs
15.5.3. Biopharmaceutical Companies
15.5.4. CMOs
15.5.5. Others
15.6. Market Value and Volume Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product
15.7.2. By Volume
15.7.3. By Material
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competitive Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Company Profiles
16.2.1. Adelphi Healthcare Packaging (The Adelphi Group Of Companies)
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Financial Overview
16.2.1.3. Product Portfolio
16.2.1.4. Strategic Overview
16.2.1.5. SWOT Analysis
16.2.2. APG Europe
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Financial Overview
16.2.2.3. Product Portfolio
16.2.2.4. Strategic Overview
16.2.2.5. SWOT Analysis
16.2.3. Bormioli Pharma S.p.a.
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Financial Overview
16.2.3.3. Product Portfolio
16.2.3.4. Strategic Overview
16.2.3.5. SWOT Analysis
16.2.4. Corning Incorporated
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Financial Overview
16.2.4.3. Product Portfolio
16.2.4.4. Strategic Overview
16.2.4.5. SWOT Analysis
16.2.5. Dalton Pharma Services
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Financial Overview
16.2.5.3. Product Portfolio
16.2.5.4. Strategic Overview
16.2.5.5. SWOT Analysis
16.2.6. DWK Life Sciences GmbH
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Financial Overview
16.2.6.3. Product Portfolio
16.2.6.4. Strategic Overview
16.2.6.5. SWOT Analysis
16.2.7. Gerresheimer AG
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Financial Overview
16.2.7.3. Product Portfolio
16.2.7.4. Strategic Overview
16.2.7.5. SWOT Analysis
16.2.8. Nipro Corporation
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Financial Overview
16.2.8.3. Product Portfolio
16.2.8.4. Strategic Overview
16.2.8.5. SWOT Analysis
16.2.9. O.Berk Company
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Financial Overview
16.2.9.3. Product Portfolio
16.2.9.4. Strategic Overview
16.2.9.5. SWOT Analysis
16.2.10. Pacific Vial
16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.10.2. Financial Overview
16.2.10.3. Product Portfolio
16.2.10.4. Strategic Overview
16.2.10.5. SWOT Analysis
16.2.11. Piramal Glass (Piramal Enterprises Ltd.)
16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.11.2. Financial Overview
16.2.11.3. Product Portfolio
16.2.11.4. Strategic Overview
16.2.11.5. SWOT Analysis
16.2.12. Schott AG
16.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.12.2. Financial Overview
16.2.12.3. Product Portfolio
16.2.12.4. Strategic Overview
16.2.12.5. SWOT Analysis
16.2.13. SDG Pharma
16.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.13.2. Financial Overview
16.2.13.3. Product Portfolio
16.2.13.4. Strategic Overview
16.2.13.5. SWOT Analysis
16.2.14. Shandong Pharmaceutical Glass Co. Ltd.
16.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.14.2. Financial Overview
16.2.14.3. Product Portfolio
16.2.14.4. Strategic Overview
16.2.14.5. SWOT Analysis
16.2.15. SiO2 Materials Science
16.2.15.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.15.2. Financial Overview
16.2.15.3. Product Portfolio
16.2.15.4. Strategic Overview
16.2.15.5. SWOT Analysis
16.2.16. Stevanato Group
16.2.16.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.16.2. Financial Overview
16.2.16.3. Product Portfolio
16.2.16.4. Strategic Overview
16.2.16.5. SWOT Analysis
16.2.17. Thermo Fisher Scientific, Inc.
16.2.17.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.17.2. Financial Overview
16.2.17.3. Product Portfolio
16.2.17.4. Strategic Overview
16.2.17.5. SWOT Analysis
16.2.18. West Pharmaceutical Services, Inc.
16.2.18.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.18.2. Financial Overview
16.2.18.3. Product Portfolio
16.2.18.4. Strategic Overview
16.2.18.5. SWOT Analysis
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers